by Eriksen Insurance | May 15, 2026 | Uncategorized
For the first time in its history, Medicare is preparing to cover weight loss drugs at scale. Beginning July 1, 2026, the new Medicare GLP-1 Bridge will give eligible Part D beneficiaries access to medications like Wegovy, Zepbound, and the newly approved Foundayo for...
by Eriksen Insurance | May 15, 2026 | Uncategorized
The Centers for Medicare and Medicaid Services refreshed its Overall Hospital Quality Star Rating this week, and the new numbers tell a familiar story. Most American hospitals are clustered in the middle of the distribution, with a small group of standouts at the top,...
by Eriksen Insurance | May 4, 2026 | Uncategorized
Medicare is about to do something it has never done before: cover prescription weight loss drugs. Starting July 1, 2026, eligible Medicare beneficiaries can get Wegovy, Zepbound, or Foundayo for just $50 a month through a new program called the Medicare GLP-1 Bridge....
by Eriksen Insurance | Apr 22, 2026 | Uncategorized
Most people already know health care is expensive, but the numbers tell a stark story. About 6 in 10 adults say they are very or somewhat worried about affording health care for themselves and their families, making it the top financial concern, ahead of food and...
by Eriksen Insurance | Apr 15, 2026 | Uncategorized
For years, the promise of GLP-1 weight loss treatment came with a catch: a weekly injection. Now, for the millions of Americans who would rather skip the needle entirely, two oral alternatives are on the market, and doctors say demand is real. Novo Nordisk’s...
by Eriksen Insurance | Mar 13, 2026 | Uncategorized
When Medicare Advantage insurers began sounding alarms about payment system changes last year, few could have predicted the scope of what followed. As 2025 drew to a close, more than 2.6 million Americans found out that the Medicare Advantage plan they’d chosen...
